Search Results Heading

MBRLSearchResults

mbrl.module.common.modules.added.book.to.shelf
Title added to your shelf!
View what I already have on My Shelf.
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Are you sure you want to remove the book from the shelf?
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
    Done
    Filters
    Reset
  • Discipline
      Discipline
      Clear All
      Discipline
  • Is Peer Reviewed
      Is Peer Reviewed
      Clear All
      Is Peer Reviewed
  • Item Type
      Item Type
      Clear All
      Item Type
  • Subject
      Subject
      Clear All
      Subject
  • Year
      Year
      Clear All
      From:
      -
      To:
  • More Filters
36 result(s) for "Menon, Raji"
Sort by:
Safety of procuring research tissue during a clinically indicated kidney biopsy from patients with lupus: data from the Accelerating Medicines Partnership RA/SLE Network
ObjectivesIn lupus nephritis the pathological diagnosis from tissue retrieved during kidney biopsy drives treatment and management. Despite recent approval of new drugs, complete remission rates remain well under aspirational levels, necessitating identification of new therapeutic targets by greater dissection of the pathways to tissue inflammation and injury. This study assessed the safety of kidney biopsies in patients with SLE enrolled in the Accelerating Medicines Partnership, a consortium formed to molecularly deconstruct nephritis.Methods475 patients with SLE across 15 clinical sites in the USA consented to obtain tissue for research purposes during a clinically indicated kidney biopsy. Adverse events (AEs) were documented for 30 days following the procedure and were determined to be related or unrelated by all site investigators. Serious AEs were defined according to the National Institutes of Health reporting guidelines.Results34 patients (7.2%) experienced a procedure-related AE: 30 with haematoma, 2 with jets, 1 with pain and 1 with an arteriovenous fistula. Eighteen (3.8%) experienced a serious AE requiring hospitalisation; four patients (0.8%) required a blood transfusion related to the kidney biopsy. At one site where the number of cores retrieved during the biopsy was recorded, the mean was 3.4 for those who experienced a related AE (n=9) and 3.07 for those who did not experience any AE (n=140). All related AEs resolved.ConclusionsProcurement of research tissue should be considered feasible, accompanied by a complication risk likely no greater than that incurred for standard clinical purposes. In the quest for targeted treatments personalised based on molecular findings, enhanced diagnostics beyond histology will likely be required.
When the unexpected upends your practice
Once again, don't hesitate to seek help: Coaches, counsellors, psychologists and psychiatrists are all professionals who can help. Remember that there is a multitude of choices, and you will discover them if you look around. Look at the pros and cons of each, before you decide. Once you have made a measured decision, trust yourself. And do not isolate yourself.
Trade Publication Article
E.U. Draft Hedge Fund Directive Needs Rewrite: AIMA
\"The particular problem with the draft directive is that it is written in such an unclear way that it is open to ambiguous interpretation,\" said the Alternative Investment Management Association (AIMA). Implementation in its current form could prove to be unworkable. It also appears to be in conflict with existing financial services directives.\"
Trade Publication Article
Top U.K. Fund May Invest up to 20% in Alternatives
Although Mr. [Frank Naylor] declined to say how much the pension fund's allocation to hedge funds would rise to, he said the new allocation would be \"significantly larger.\" At end-2007, the pension fund had 5% allocated to hedge funds.
Trade Publication Article
Blue chip CEOs in the firing line
\"There is definitely a strong desire to curb excessive executive pay, which is such an emotive issue given the remarkable sums of money involved,\" said Luke Hildyard, policy lead for stewardship and corporate governance at the Pensions and Lifetime Savings ­Association, whose members hold around £900billion in assets.
Blue chip CEOs in the firing line
\"There is definitely a strong desire to curb excessive executive pay, which is such an emotive issue given the remarkable sums of money involved,\" said Luke Hildyard, policy lead for stewardship and corporate governance at the Pensions and Lifetime Savings Association, whose members hold around Pounds 900 billion in assets. Investor advisory groups such as ShareSoc have also been vocal. Roger Lawson, deputy chairman of ShareSoc, said: \"This is outrageous. I cannot see why we have to pay CEOs such enormous sums, especially when underlying financials have not been particularly good.\" Daniel Summerfield, co-head of responsible investment at USS, the second largest pension scheme in the UK, added: \"Every time pay awards are voted down, the boards of UK plc should recognise the strong signal being sent to them and respond appropriately.\"
Blue chip CEOs in the firing line
\"There is definitely a strong desire to curb excessive executive pay, which is such an emotive issue given the remarkable sums of money involved,\" said Luke Hildyard, policy lead for stewardship and corporate governance at the Pensions and Lifetime Savings Association, whose members hold around Pounds 900 billion in assets. Investor advisory groups such as ShareSoc have also been vocal. Roger Lawson, deputy chairman of ShareSoc, said: \"This is outrageous. I cannot see why we have to pay CEOs such enormous sums, especially when underlying financials have not been particularly good.\" Daniel Summerfield, co-head of responsible investment at USS, the second largest pension scheme in the UK, added: \"Every time pay awards are voted down, the boards of UK plc should recognise the strong signal being sent to them and respond appropriately.\"
Horlick Calls Tchenguiz's Bluff over Board
In the letter seen by Reuters, Bramdean's lawyers Simmons & Simmons noted Financial Services Authority rules on misleading statements and practices alongside the following comment: \"The company finds it very difficult to believe the statements made by [Elsina] and KBC Peel Hunt that the Requisition has more than 50% support and is concerned that this is a tactic designed to influence the investment and voting decisions of some of the marginal shareholders.\"
Trade Publication Article
U.K. Hedge Fund Firm Bramdean Receives Offer
One investor in Bramdean, who spoke on the condition of anonymity, told Reuters: \"It will be relatively easy to assess the value of the [firm] given that it has so much of its holdings in cash. As an investor we would be reluctant to give our backing to any offer that undervalues the fund significantly.\"
Trade Publication Article